Difference between revisions of "Osocimab (BAY-1213790)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Warner-admin moved page Osocimab (BAY 1213790) to Osocimab (BAY-1213790) without leaving a redirect) |
|||
| Line 4: | Line 4: | ||
==Preliminary data== | ==Preliminary data== | ||
===[[Venous thromboembolism]]=== | ===[[Venous thromboembolism]]=== | ||
| − | # '''FOXTROT:''' Weitz JI, Bauersachs R, Becker B, Berkowitz SD, Freitas MCS, Lassen MR, Metzig C, Raskob GE. Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial. JAMA. 2020 Jan 14;323(2):130-139. [https:// | + | # '''FOXTROT:''' Weitz JI, Bauersachs R, Becker B, Berkowitz SD, Freitas MCS, Lassen MR, Metzig C, Raskob GE. Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial. JAMA. 2020 Jan 14;323(2):130-139. [https://doi.org/10.1001/jama.2019.20687 link to original article] [http://www.ncbi.nlm.nih.gov/pmc/articles/pmc6990695/ link to PMC article] [https://pubmed.ncbi.nlm.nih.gov/31935028/ PubMed] |
==Also known as== | ==Also known as== | ||
Revision as of 23:24, 2 September 2023
Mechanism of action
Anti-Factor XIa antibody
Preliminary data
Venous thromboembolism
- FOXTROT: Weitz JI, Bauersachs R, Becker B, Berkowitz SD, Freitas MCS, Lassen MR, Metzig C, Raskob GE. Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial. JAMA. 2020 Jan 14;323(2):130-139. link to original article link to PMC article PubMed
Also known as
- Code name: BAY-1213790